Why COVID-19 trials should be blinded (as any other one) | Pacheco | Journal of Evidence-Based Healthcare

Article Tools

How to cite item

User

Notifications

Journal Content
Browse

Open Journal Systems

Why COVID-19 trials should be blinded (as any other one)

Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Carolina de Oliveira Cruz Latorraca, Rachel Riera

Keywords

Blinding. Clinical trials. COVID-19.

Full Text:

PDF

DOI: http://dx.doi.org/10.17267/2675-021Xevidence.v2i1.2841

Refbacks

There are currently no refbacks.

Copyright (c) 2020 Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Carolina de Oliveira Cruz Latorraca, Rachel Riera

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This journal has been indexed and/or catalogued in the following database:

Journal of Evidence-Based Healthcare | ISSN 2675-021X

Updated 01/03/2020